TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+144.2%
5Y CAGR+124.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+144.2%/yr
Annual compound
5Y CAGR
+124.5%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
57x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.05M | -17.4% |
| 2024 | $7.32M | +72.7% |
| 2023 | $4.24M | +921.7% |
| 2022 | $415000.00 | +2493.8% |
| 2021 | $16000.00 | -84.9% |
| 2020 | $106000.00 | -80.8% |
| 2019 | $552000.00 | - |